This profile has not been claimed and data may not be accurate.
65th percentile
55th percentile
UCSF professor and Arc Institute scientist co-founding biotech companies at the AI-biology frontier
Credibility
Domain Expertise · 85th percentile
- Deep research credibility: h-index 52 and 14,194 citations across 289 works (OpenAlex).
- Identified as a researcher with a substantial publication record (OpenAlex).
Relationship Matrix
Founder score
- 92%Probability of being accurate (92%)Current co-founder of Tahoe Therapeutics (formerly Vevo) and Exai Bio, both active biotech companies.
- 90%Probability of being accurate (90%)Exai Bio has raised $139M in total funding per its LinkedIn company profile and SEC Form D filing.
- 90%Probability of being accurate (90%)Deep research credibility: h-index 52 and 14,194 citations across 289 works (OpenAlex).
- 90%Probability of being accurate (90%)Identified as a researcher with a substantial publication record (OpenAlex).
- 88%Probability of being accurate (88%)Recognized with the Vilcek Foundation prize for his multidisciplinary approach to cancer biology.
- 85%Probability of being accurate (85%)Exai Bio, Tahoe Therapeutics, and Therna Biosciences all have co-founders alongside Hani Goodarzi.
- 82%Probability of being accurate (82%)Tahoe Therapeutics (formerly Vevo) has raised $72M in total funding per its LinkedIn company profile.
- 72%Probability of being accurate (72%)Therna Biosciences, which Hani co-founded in 2025, has $20M in total funding.
- 70%Probability of being accurate (70%)Identified researcher on Hugging Face as @hanig (Hani Goodarzi).
Investor score
- 92%Probability of being accurate (92%)Venture Partner at Amplify Partners, an early-stage enterprise venture capital firm.
- 75%Probability of being accurate (75%)Has approximately 1 year of investing experience as Venture Partner at Amplify Partners (since April 2026).
What you likely need
You sit at a rare intersection of deep scientific credibility, serial company-building, and now institutional investing — Festival events should reflect all three modes simultaneously. The highest-leverage gatherings for you are intimate dinners with crossover biotech-AI investors who can move fast on Therna's seed/Series A, and roundtables where your Arc Institute Virtual Cell work positions you as the defining scientist-investor in the AI-biology wave. You also need a deliberate, protected space to step back from the operational grind of three companies and a faculty role — a small wellbeing session with other scientist-founders running parallel ventures would be unusually valuable.
Would you attend these IRL Festival events?
We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.
- fundraisingA closed dinner with 8–10 crossover biotech-AI seed and Series A investors (think Andreessen Bio, 8VC, Dimension Capital) specifically convened around RNA-targeting and epigenetic platforms, where Therna Biosciences is the featured founder story
- introsAn Amplify Partners co-investment roundtable with fellow Amplify portfolio founders and select AI-biology angels to surface live deal flow you can co-lead and build a visible track record alongside your Amplify Venture Partner role
- positioningA small Arc Institute and Convergent Research affiliate dinner with top ML-biology researchers and science journalists to publicly surface the Virtual Cell initiative and cement your positioning at the AI-biology frontier
- fundraisingA strategic roundtable with BD and corporate venture leads from Roche, Illumina, and Guardant Health to pressure-test whether Exai Bio's liquid biopsy platform is primed for a Series B or a diagnostics-major partnership at the $139M raised inflection point
- hiringA Tahoe Therapeutics hiring dinner with top computational biology and ML engineering talent from Genentech, Recursion, and Arc Institute to build a structured pipeline that matches Tahoe's 40% YoY headcount growth trajectory
- positioningA build-in-public happy hour with founder-researchers who have successfully open-sourced ML biology models (ESMFold, Evo, OpenFold communities) to map a GitHub and open-source release strategy for your lab and company tools
- wellbeingAn intimate offsite dinner for scientist-founders simultaneously holding faculty, company, and fund roles — peers like yourself navigating the Recursion, Insitro, and Arc Institute orbit — explicitly designed to protect deep research time and share operating structures that prevent burnout